Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Optiscan Imaging Limited ( (AU:OIL) ).
Optiscan Imaging Limited reported a 17.6% decrease in revenue for the year ending June 30, 2025, primarily due to reduced orders from Carl Zeiss Meditec. Despite this, the company increased its research and development incentive income by 142% and unveiled two new medical imaging devices. The company’s net assets decreased significantly, reflecting higher cash outflows driven by increased R&D and commercial activities.
More about Optiscan Imaging Limited
Optiscan Imaging Limited operates in the medical imaging industry, focusing on developing advanced microscopic imaging devices. The company offers products like InForm™ for pathology and InSpecta™ for veterinary medicine, with a market focus on enhancing clinical validation and commercial readiness through strategic initiatives.
Average Trading Volume: 114,630
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$71.84M
For detailed information about OIL stock, go to TipRanks’ Stock Analysis page.